---
category: news
title: "Israel’s Immunai to use $215 mil. investment to develop, test new drugs"
excerpt: "Israeli-American biotech company Immunai is best known for its development of the world’s largest data atlas of clinically annotated single-cell immune data."
publishedDateTime: 2021-06-19T20:00:00Z
originalUrl: "https://www.jpost.com/health-and-wellness/israels-immunai-to-use-215-mil-investment-to-develop-test-new-drugs-683266"
webUrl: "https://www.jpost.com/health-and-wellness/israels-immunai-to-use-215-mil-investment-to-develop-test-new-drugs-683266"
ampWebUrl: "https://m.jpost.com/health-and-wellness/israels-immunai-to-use-215-mil-investment-to-develop-test-new-drugs-683266/amp"
cdnAmpWebUrl: "https://m-jpost-com.cdn.ampproject.org/c/s/m.jpost.com/health-and-wellness/israels-immunai-to-use-215-mil-investment-to-develop-test-new-drugs-683266/amp"
type: article

provider:
  name: The Jerusalem Post Blogs
  domain: jpost.com

topics:
  - AI

images:
  - url: "https://images.jpost.com/image/upload/f_auto,fl_lossy/t_JM_ArticleMainImageFaceDetect/485949"
    width: 640
    height: 428
    isCached: true

secured: "OXfAnEb0mkc/HlIDV1VMUuz7x85vjuD2AGpryjmUEr0XxT+0eYAv9YMDFUyEDxJJXvssx5dLFwj2NSaHfS7S+hhV9QC1sqcEesEDsNltwYjYJnQQDIOahDwpDUX+7tYLJVjTt7yqe9X/BTu/72XiAMDLHF3yn1gaT8s2SD3AHFNpy6YWYf2tYRIxUVRhj7o+Po9U6daG4D+mLJPOaORb9P6a3JDrFSNjzw1vPaK/ZCEw9R7iWWIqddPz91cFCG7SacMO3Hx7We79YurElC+w/Q5Z9iCaK4HhVctr9aywyAhfvcc5n4Y6JUsrceM7cyfBC2XwLeuJvRlQ7k/Sal8aKeDh7obQSLhACQf4qYTMnqg=;WElYKM2fzSA3t0Vzcx4DBQ=="
---

